Bayer Walks Away From Schiff After Reckitt Trumps Takeover Bid

Bayer Walks Away From Schiff After Reckitt Trumps Takeover Bid

Chris Ratcliffe/Bloomberg

The offer from Reckitt Benckiser values Schiff at about 28 times earnings before interest, taxes, depreciation and amortization.